Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy

Muscle and Nerve

Volumn 27, Issue 6, 2003, Pages 743-751

  Winkel, Léon P F ^a   Kamphoven, Joep H J ^b   Van Den Hout, Hannerieke J M P ^a   Severijnen, Lies A ^b   Van Doorn, Pieter A ^b   Reuser, Arnold J J ^b   Van Der Ploeg, Ans T ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acid maltase deficiency; Enzyme replacement therapy; Glycogenosis; Pompe's disease; Recombinant human glucosidase

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE; RECOMBINANT ENZYME;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; ENZYME DEFICIENCY; ENZYME REPLACEMENT; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN TISSUE; INFANT; LYSOSOME STORAGE DISEASE; MALE; MORPHOLOGY; MUSCLE BIOPSY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; TREATMENT OUTCOME;

ALPHA-GLUCOSIDASES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; LYSOSOMES; MALE; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOCYTES, SMOOTH MUSCLE; PERIPHERAL NERVES; RABBITS; RECOMBINANT FUSION PROTEINS; SCHWANN CELLS; TREATMENT OUTCOME;

EID: 0038546958     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10381     Document Type: Article

References (29)

1. Bijvoet AG, van de Kamp EH, Kroos MA, Ding JH, Yang BZ, Visser P, Bakker CE, Verbeet MP, Oostra BA, Reuser AJ, Van der Ploeg AT. Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 1998;7:53-62.
2. Bijvoet AG, Van Hirtum H, Kroos MA, Van de Kamp EH, Schoneveld O, Visser P, Brakenhoff JP, Weggeman M, Van Corven EJ, Van der Ploeg AT, Reuser AJ. Human acid alphaglucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet 1999; 8:2145-2153.
3. Bijvoet AG, Van Hirtum H, Vermey M, Van Leenen D, Van der Ploeg AT, Mooi WJ, Reuser AJ. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model. J Pathol 1999;189:416-424.
4. Bijvoet AGA, Kroos MA, Pieper FR, de Boer HA, Reuser AJJ. Van der Ploeg AT, Verbeet MP. Expression of cDNA-encoded human acid α-glucosidase in milk of transgenic mice. Biochim Biophys Acta 1996;1308:93-96.
5. Bijvoet AGA, Kroos MA, Pieper FR, Van der Vliet M, De Boer HA, Van der Ploeg AT, Verbeet MP, Reuser AJJ. Recombinant human acid α-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice. Hum Mol Genet 1998;7:1815-1824.
6. Braunsdorf WE. Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe's disease). Neurosurgery 1987;21:748-749.
7. 4 fixative which selectively contrasts glycogen. J Ultrastruct Res 1973;42:29-50.
8. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001;345:9-16.
9. Engel AG, Gomez MR, Seybold ME, Lambert EH. The spectrum and diagnosis of acid maltase deficiency. Neurology 1973;23:95-106.
10. Fuller M, Van der Ploeg A, Reuser AJJ, Anson DS, Hopwood JJ. Isolation and characterisation of a recombinant, precursor form of lysosomal acid α-glucosidase. Eur J Biochem 1995; 234:903-909.
11. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001;91:534-551.
12. Hesselink RP, Gorselink M, Schaart G, Wagenmakers AJ, Kamphoven J, Reuser AJ, Van der Vusse GJ, Drost MR. Impaired performance of skeletal muscle in alpha-glucosidase knockout mice. Muscle Nerve 2002;25:873-883.
13. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II; acid α-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Valle D, Sly WS, editors. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill; 2000. p 3389-3420.
14. Kikuchi T, Yang HW, Pennybacker M, Ichihara N, Mizutani M, Van Hove JLK, Chen YT. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest 1998;101:827-833.
15. Makos MM, McComb RD, Adickes ED, Bennett DR. Acid maltase deficiency and basilar artery aneurysms: a report of a sibship. Neurology 1985;35(suppl 1):193-194.
16. Mancall EL, Aponte GE, Berry RG. Pompe's disease (diffuse glycogenosis) with neuronal storage. J Neuropathol Exp Neurol 1965;24:85-96.
17. Martin JJ, De Barsy T, De Schrijver LJG, Palladini G. Acid maltase deficiency (type II glycogenosis). Morphological and biochemical study of a childhood phenotype. J Neurol Sci 1976;30:155-166.
18. Martin JJ, De Barsy T, Van Hoof F, Palladini G. Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol 1973;23:229-244.
19. Matsuoka Y, Senda Y, Hirayama M, Matsui T, Takahashi A. Late-onset acid maltase deficiency associated with intracranial aneurysm. J Neurol 1988;235:371-373.
20. Schiffmann R, Kopp JB, Austin HA III, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285:2743-2749.
21. Schultz E, Jaryszak DL, Gibson MC, Albright DJ. Absence of exogenous satellite cell contribution to regeneration of frozen skeletal muscle. J Muscle Res Cell Motil 1986;7:361-367.
22. Schultz E, McCormick KM. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 1994;123:213-257.
23. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 2000;137:283-285.
24. Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, CrommeDijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 2000; 356:397-398.
25. Van den Hout JM, Reuser AJ, de Klerk JB, Arts WF, Smeitink JA, Van der Ploeg AT. Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk. J Inherit Metab Dis 2001;24:266-274.
26. Van der Ploeg AT, Bolhuis PA, Wolterman RA, Visser JW, Loonen MCB, Busch HFM, Reuser AJJ. Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells. J Neurol 1988;235:392-396.
27. Van der Ploeg AT, Kroos M, Van Dongen JM, Visser WJ, Bolhuis PA, Loonen MC, Reuser AJJ. Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid α-glucosidase. J Neurol Sci 1987; 79:327-336.
28. Van Hove JL, Yang HW, Wu JY, Brady RO, Chen YT. High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci USA 1996;93:65-70.
29. Watt DJ, Morgan JE, Clifford MA, Partridge TA. The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat Embryol 1987;175:527-536.